1. Department of Pediatric Oncology, Dana-Farber Cancer Institute,
2. Division of Hematology/Oncology, Boston Children’s Hospital,
3. Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, and
4. Department of Pathology, Boston Children’s Hospital, Harvard Medical School, Boston, MA;
5. Department of Pediatrics, Golisano Children’s Hospital, University of Rochester School of Medicine and Dentistry, Rochester, NY;
6. Division of Pediatric Hematology/Oncology, McMaster University, Hamilton, ON, Canada;
7. Division of Pediatric Oncology, San Jorge Children’s Hospital, San Juan, Puerto Rico;
8. Division of Pediatric Hematology/Oncology, Children’s Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, NY;
9. Department of Pediatric Oncology, Roswell Park Cancer Institute, Buffalo, NY;
10. Oishei Children's Hospital, University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY;
11. Division of Hematology and Oncology, Hospital Sainte-Justine, University of Montreal, Montreal, QC, Canada;
12. Division of Hematology-Oncology, Centre Hospitalier Universitaire de Quebec–Université Laval, Quebec City, QC, Canada;
13. Inova Fairfax Hospital for Children, Falls Church, VA;
14. Division of Pediatric Oncology, Columbia University Medical Center, Morgan Stanley Children’s Hospital of New York–Presbyterian, New York, NY; and
15. Division of Pediatric Hematology-Oncology, Hasbro Children’s Hospital, Warren Alpert Medical School of Brown University, Providence, RI